指南与共识组学、生物样本库与精准医学临床试验与 GCP

脓毒症血液转录组学共识框架

A consensus blood transcriptomic framework for sepsis.
指南 / 共识 · Nat Med · 2025-09-30

该共识汇总MARS项目(n=678)与GAinS研究(n=444,随访样本n=817)的血液转录组数据,提出三种共识转录组亚型(CTS1–CTS3),并在VANISH试验(n=176)及乌干达地区医院疑似脓毒症住院患者(n=128)中验证其稳健性;事后分析发现接受糖皮质激素治疗的CTS2患者存在有害信号。

要点

  • 三种共识转录组亚型CTS1、CTS2、CTS3在独立队列中分类稳健。
  • CTS2患者接受糖皮质激素治疗在事后分析中显示有害信号。
  • 该框架可统一不同脓毒症转录组亚型分组,辅助临床试验设计。

核心结论

  • CTS分类方法将不同的脓毒症转录组亚型分组统一为稳健、可重复的框架,有助于生物学解释并可能辅助临床试验设计以推进脓毒症精准医学。

研究设计与样本

  • 共识框架研究汇总MARS项目(n=678,ICU入院时采样)与GAinS研究(n=444,ICU入院时采样;随访样本n=817)的血液转录组数据。
  • 在VANISH随机对照试验(n=176)及乌干达地区医院疑似脓毒症住院患者(n=128)中评估CTS分类的稳健性。

主要发现

  • CTS1特征包括典型炎症通路基因激活、更明显的内皮激活及整体未成熟中性粒细胞主题。
  • CTS2特征包括血红素代谢通路基因激活、纤溶紊乱及血小板和嗜酸性粒细胞特征。
  • CTS3与移植物排斥反应激活、干扰素信号及抗凝功能相关基因有关,并伴淋巴细胞和非经典单核细胞特征。
  • 对伪随机队列的事后分析及VANISH试验数据的再分析发现,接受糖皮质激素治疗的CTS2患者存在有害信号。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis is a life-threatening condition driven by a maladaptive host response to infection. To establish a standardized blood transcriptomic subtype model, we aggregated blood transcriptomics data from two major sepsis cohorts: the Molecular Diagnosis and Risk Stratification of Sepsis (MARS) project (n = 678 sampled on intensive care unit admission; ClinicalTrials.gov registration no. NCT01905033 ) and the Genomic Advances in Sepsis (GAinS) study (n = 444 sampled on intensive care unit admission and n = 817 follow-up samples; ClinicalTrials.gov registration no. NCT00131196 ). We demonstrate a strong interconnection across three separate classification methods, resulting in the proposed groupings of three consensus transcriptomic subtypes (CTSs). The distinguishing characteristics of CTS1 included gene activation of typical inflammatory pathways, more pronounced endothelial activation and an overall immature neutrophil theme. CTS2 was characterized by gene activation of a heme metabolism pathway, fibrinolytic disturbances and platelet and eosinophil signatures. CTS3 was associated with genes involved in the activation of allograft rejection, interferon signaling and anticoagulation functions, together with lymphocyte and nonclassical monocyte features. Evaluating CTS classification in independent patient cohorts, specifically the vasopressin vs noradrenaline as initial therapy in septic shock (VANISH) randomized controlled trial (n = 176; ISRCTN registration no. ISRCTN20769191 ) and patients hospitalized with suspected sepsis at a district hospital in Uganda (n = 128), ascertained the robustness of our approach. Notably, post hoc analysis of a pseudo-randomized cohort, along with a reanalysis of the VANISH trial data, unmasked a harmful signal in CTS2-assigned patients treated with corticosteroids. The CTS classification method aligns diverse sepsis transcriptomic subgroupings into a robust, reproducible framework, thereby enabling biological interpretation and potentially assisting aspects of clinical trial design to advance precision medicine in sepsis.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Scicluna BP, Cano-Gamez K, Burnham KL, et al. A consensus blood transcriptomic framework for sepsis. Nat Med. 2025. PMID: 41028542. doi:10.1038/s41591-025-03964-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。